🇺🇸 FDA
Patent

US 12054749

Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

granted A61KA61K2039/5254A61K2039/53

Quick answer

US patent 12054749 (Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/5254, A61K2039/53, A61K2039/55, A61K39/155